Olbas Oil

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Eucalyptus Oil; Mint oil, partly dementholised ; Cajuput Oil ; Clove Oil; Juniper Oil ; Levomenthol; Methyl Salicylate

Available from:

GR Lane Health Products Ltd

ATC code:

R05X

INN (International Name):

Eucalyptus Oil; Mint oil, partly dementholised ; Cajuput Oil ; Clove Oil; Juniper Oil ; Levomenthol; Methyl Salicylate

Dosage:

Unknown

Pharmaceutical form:

Inhalation vapour, liquid

Prescription type:

Product not subject to medical prescription

Therapeutic area:

OTHER COLD PREPARATIONS

Authorization status:

Marketed

Authorization date:

1988-09-01

Patient Information leaflet

READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
This medicine is available without prescription. However, you still
need to use Olbas Oil carefully to get the best results from it.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or advice.
•
You must contact a doctor if your symptoms worsen or do
not improve.
•
If you notice any side effect, please tell your doctor or
pharmacist.
In this leaflet:
1. What Olbas Oil is and what it is used for
2. Before you use Olbas Oil
3. How to use Olbas Oil
4. Possible side effects
5. How to store Olbas Oil
6. Further information
6. FURTHER INFORMATION
What Olbas Oil contains
The active substances (w/w) are:
Cajuput Oil
..................................................................18.5%
Clove Oil
........................................................................
0.1%
Eucalyptus Oil
.........................................................35.45%
Juniper Oil
......................................................................
2.7%
Levomenthol
................................................................ 4.1%
Mint Oil, Partly Dementholised ....................35.45%
Methyl Salicylate
......................................................... 3.7%
What Olbas Oil looks like and contents of the pack
Olbas Oil is a pale green, transparent inhalation vapour liquid. It is
available in bottles containing 10ml and 28ml.
Marketing Authorisation Holder and Manufacturer
G. R. Lane Health Products Limited,
Sisson Road,
Gloucester,
GL2 0GR,
United Kingdom
Tel: [phone]
Email: [e-mail]
This leaflet was last approved May 2018 3010-01
INHALANT
DECONGESTANT
_oil_
_oil_
_Olbas_
_Olbas_
3010-01 Eire Olbas PIL.indd 1-2
02/05/2018 15:32
1. WHAT OLBAS OIL IS AND WHAT IT IS USED FOR
Olbas Oil is a blend of pure plant oils for the relief of nasal
congestion by inhalation. When applied to the skin, Olbas Oil also
relieves the symptoms of muscular pain and stiffness in

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Olbas Oil
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Inhalation vapour, liquid
Cutaneous liquid
A pale green transparent liquid.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As
an antiseptic,
decongestant
and analgesic
for
topical
use
in relief
of
nasal
congestion and oropharyngeal
inflammation and of pain due to muscular trauma.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Inhalation:
Adults and children over 5 years: Sprinkle 2/3 drops on a
handkerchief, or add to hot water and inhale the vapour.
Topical:
Apply lightly to the painful area 3 times daily.
4.3 CONTRAINDICATIONS
(i)
Hypersensitivity to the active substances.
(ii)
Use on broken skin.
(iii)
Use in infants or young children under 5 years.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If there is no improvement or there is an aggravation of the condition
consult the doctor.
Active substances
% w/w
Cajuput Oil
18.50
Clove Oil
0.10
Eucalyptus Oil
35.45
Juniper Oil
2.70
Menthol
4.10
Mint Oil, Partly Dementholised
35.45
Methyl Salicylate
3.70
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_8_
_C_
_R_
_N_
_ _
_2_
_2_
_0_
_6_
_8_
_8_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
No interaction studies have been performed.
4.6 FERTILITY, PREGNANCY AND LACTATION
There are no reports of adverse effects when used du